Eikonizo is developing life-changing therapies by creating brain-penetrant small molecules and deploying in vivo target engagement techniques to accelerate the identification of therapeutics. Their first program is focused on a disease-modifying therapeutics for neurodegenerative diseases.

Biotechnology

Eikonizo Therapeutics

Janice Kranz

Alix Gregory

Frederick 'Al' Schroeder

Jacob Hooker

Al Schroeder

Tonya Gilbert

Florence Wagner

The Research and Development team at Eikonizo Therapeutics focuses on designing and synthesizing brain-penetrant small molecules, utilizing in vivo target engagement techniques to identify potential therapeutics. Their primary goal is to develop disease-modifying treatments for neurodegenerative diseases by leveraging advanced translational research and medicinal chemistry.

Research and Development

Leadership Team

Advisory

Research and Development

About

Team members

Other teams at Eikonizo Therapeutics

Leadership Team

Advisory